Otto Metzger Filho
Harvard University
H-index: 38
North America-United States
Top articles of Otto Metzger Filho
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Adjuvant chemotherapy with or without atezolizumab for stage II and III triple-negative breast cancer: final analysis of the ALEXANDRA/IMpassion030 phase 3 trial | European Journal of Cancer | H McArthur A Bailey S Saji S El-Abed G Nader Marta | 2024/3/1 |
Abstract GS01-03: Adding atezolizumab to adjuvant chemotherapy for stage II and III triple-negative breast cancer is unlikely to improve efficacy: interim analysis of the … | Cancer Research | Michail Ignatiadis Andrew Bailey Heather McArthur Sarra El-Abed Evandro de Azambuja | 2024/5/2 |
Axillary nodal response to neoadjuvant T-DM1 combined with pertuzumab in a prospective phase II multi-institution clinical trial | Journal of the American College of Surgeons | Anna Weiss Qingchun Jin Adrienne G Waks Denise Yardley Laura M Spring | 2024/3/1 |
Abstract GS03-07: Protocol-defined biomarker analysis in the PALLAS (AFT-05) adjuvant trial: Genomic subtype derived from RNA sequencing of HR+/HER2-early breast cancer | Cancer Research | Daniel Stover Dominik Hlauschek Erica Mayer W Fraser Symmans Mark Watson | 2024/5/2 |
Qualification of a multiplexed tissue imaging assay and detection of novel patterns of HER2 heterogeneity in breast cancer | NPJ Breast Cancer | Jennifer L Guerriero Jia-Ren Lin Ricardo G Pastorello Ziming Du Yu-An Chen | 2024/1/2 |
Abstract PS09-02: Event-free Survival by Residual Cancer Burden (RCB) and Intratumor HER2 Heterogeneity after Neoadjuvant T-DM1 and Pertuzumab for Early-stage HER2-positive … | Cancer Research | Otto Metzger Se Eun Kim Nabihah Tayob Giuseppe Viale Denise Yardley | 2024/5/2 |
Abstract PO3-16-03: Investigating HER2DX genomic assay concordance within HER2-positive breast cancer | Cancer Research | Fara Brasó-Maristany Laia Paré Guillermo Villacampa Mercedes Marín-Aguilera Paul Spellman | 2024/5/2 |
Genomic mechanisms of resistance to tyrosine kinase inhibitors in HER2 amplified breast cancer | Cancer Research | Heather A Parsons Conor Messer Katheryn Santos Brian P Danysh Melissa E Hughes | 2023/4/4 |
Towards improvement of oncology care through digital technology: A snapshot of Resilience remote patient monitoring (RPM) system implementation across 19 hospitals in Europe. | Arlindo R Ferreira Antoine Lemaire Joseph Rodriguez Jessica Grosjean Joana M Ribeiro | 2023/6/1 | |
Abstract OT1-04-01: AMEERA-6: Phase 3 Study of Adjuvant Amcenestrant Versus Tamoxifen for Patients With Hormone Receptor-Positive Early Breast Cancer, Who Have Discontinued … | Cancer Research | Otto Metzger Christina Herold Coralie Poncet Heidi De Swert Jose Casas-Martin | 2023/3/1 |
ASCENT-05/OptimICE-RD (AFT-65): Phase 3, randomized, open-label study of adjuvant sacituzumab govitecan (SG)+ pembrolizumab (pembro) vs pembro±capecitabine (cape) in patients … | Sara M Tolaney Angela DeMichele Toshimi Takano Hope S Rugo Charles Perou | 2023/6/1 | |
Abstract P5-14-01: Transcriptomic insights into lobular breast cancer biology: a retrospective analysis of the MINDACT clinical trial | Cancer Research | Christine Desmedt Ha-Linh Nguyen François Richard Sabine Linn Otto Metzger | 2023/3/1 |
Assessment of the HER2DX assay in patients with ERBB2-positive breast cancer treated with neoadjuvant paclitaxel, trastuzumab, and pertuzumab | JAMA oncology | Adrienne G Waks Esther R Ogayo Laia Paré Mercedes Marín-Aguilera Fara Brasó-Maristany | 2023/6/1 |
Abstract PD17-05: Development and Validation of a Composite Biomarker Predictive of Palbociclib+ Endocrine Treatment Benefit in Early Breast Cancer: PENELOPE-B and PALLAS Trials | Cancer Research | Sibylle Loibl Carsten Denkert Yuan Liu Erik S Knudsen Angela DeMichele | 2023/3/1 |
Abstract P2-03-13: Breast Cancer Index (BCI) identifies fewer patients with high risk of late recurrence and high likelihood of benefit from extended endocrine therapy with … | Cancer Research | Otto Metzger Neeta Parimi Natalia Siuliukina Yi Zhang Kai Treuner | 2023/3/1 |
Survival Outcomes in Premenopausal Patients With Invasive Lobular Carcinoma | JAMA network open | Tae In Yoon Joon Jeong Seokwon Lee Jai Min Ryu Young Joo Lee | 2023/11/1 |
Abstract P6-05-50: Lobular Breast Cancer Alliance Inc. Survey of Individuals with Metastatic Invasive Lobular Carcinoma | Cancer Research | Laurie B Hutcheson Janice Axelrod Ann Camden Donna J Charlevoix Tracy A Cushing | 2023/3/1 |
Abstract P6-05-10: An international survey on invasive lobular breast cancer (ILC) reveals gaps in knowledge and top priority research areas | Cancer Research | Steffi Oesterreich Leigh Pate ADRIAN V LEE Rachel C Jankowitz Patrick Derksen | 2023/3/1 |
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer | Cancer Research | Francisco Hermida-Prado Yingtian Xie Shira Sherman Zsuzsanna Nagy Douglas Russo | 2023/10/2 |
Abstract P1-04-05: Independent validation of the HER2DX genomic test in HER2-positive breast cancer treated with neoadjuvant paclitaxel, trastuzumab and pertuzumab (THP): a … | Cancer Research | Adrienne Waks Esther R Ogayo Laia Paré Mercedes Marín-Aguilera Fara Brasó-Maristany | 2023/3/1 |
